Tibes, Raoul <br/><br/>
Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques.  [electronic resource] 

 -  Leukemia research  Jun 2012 
 - 664-71 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2012.02.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--analysis<br/>Clinical Trials as Topic--trends<br/>Endpoint Determination--trends<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis<br/>Medical Oncology--methods<br/>Models, Biological<br/>Monitoring, Physiologic--methods<br/>Prognosis<br/>Sensitivity and Specificity<br/>Treatment Outcome